First Manhattan CO Moderna, Inc. Transaction History

First Manhattan CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $21,427 - $28,975	-251 Reduced 34.57%	475 $50,000
Q4 2023 Feb 13, 2024	BUY	$69.51 - $104.43 $69 - $104	1 Added 0.14%	726 $72,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $1,185 - $1,605	-10 Reduced 1.36%	725 $88,000
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $16,686 - $24,233	-123 Reduced 14.34%	735 $112,000
Q4 2022 Feb 14, 2023	SELL	$118.38 - $210.04 $277,837 - $492,963	-2,347 Reduced 73.23%	858 $154,000
Q2 2022 Aug 15, 2022	SELL	$117.13 - $176.59 $468 - $706	-4 Reduced 0.12%	3,205 $457,000
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $29,844 - $55,471	-236 Reduced 6.85%	3,209 $552,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $625,521 - $1.02 Million	2,770 Added 410.37%	3,445 $874,000
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $24,565 - $41,845	-225 Reduced 25.0%	675 $88,000
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $16,435 - $42,465	-250 Reduced 21.74%	900 $94,000
Q3 2020 Nov 12, 2020	BUY	$54.34 - $94.85 $46,189 - $80,622	850 Added 283.33%	1,150 $81,000
Q2 2020 Aug 14, 2020	BUY	$29.67 - $80.0 $8,901 - $24,000	300 New	300 $19,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

Stay updated on First Manhattan CO with notifications on news.